The use of antibodies against the IL-2 receptor in transplantation
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in Current Opinion in Immunology
- Vol. 10 (5) , 507-512
- https://doi.org/10.1016/s0952-7915(98)80215-x
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- JAKS AND STATS: Biological ImplicationsAnnual Review of Immunology, 1998
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3Science, 1995
- Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 ReceptorScience, 1994
- Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-7 ReceptorScience, 1993
- The IL-2/IL-2 receptor system: a target for rational immune interventionImmunology Today, 1993
- The IL-2/IL-2 receptor system: A current overviewCell, 1993
- Cloning of the γ Chain of the Human IL-2 ReceptorScience, 1992
- Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal AllograftsNew England Journal of Medicine, 1990
- PROLONGATION OF PRIMATE RENAL ALLOGRAFT SURVIVAL BY ANTI-TAC, AN ANTI-HUMAN IL-2 RECEPTOR MONOCLONAL ANTIBODYTransplantation, 1989